These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17388755)

  • 21. Non-clinical safety and pharmacokinetic evaluations of propylene glycol aerosol in Sprague-Dawley rats and Beagle dogs.
    Werley MS; McDonald P; Lilly P; Kirkpatrick D; Wallery J; Byron P; Venitz J
    Toxicology; 2011 Sep; 287(1-3):76-90. PubMed ID: 21683116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimum peripheral drug deposition in patients with cystic fibrosis.
    Brand P; Meyer T; Häussermann S; Schulte M; Scheuch G; Bernhard T; Sommerauer B; Weber N; Griese M
    J Aerosol Med; 2005; 18(1):45-54. PubMed ID: 15741773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate.
    Laube BL; Jashnani R; Dalby RN; Zeitlin PL
    Chest; 2000 Oct; 118(4):1069-76. PubMed ID: 11035679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurements of electrodynamic effects on the deposition of MDI and DPI aerosols in a replica cast of human oral-pharyngeal-laryngeal airways.
    Ali M; Mazumder MK; Martonen TB
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):35-44. PubMed ID: 18800879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel method to aerosolize powder for short inhalation exposures at high concentrations: isolated rat lungs exposed to respirable diesel soot.
    Gerde P; Ewing P; Låstbom L; Ryrfeldt A; Waher J; Lidén G
    Inhal Toxicol; 2004 Jan; 16(1):45-52. PubMed ID: 14744664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary deposition of monodisperse aerosols in patients with chronic obstructive pulmonary disease.
    Meyer T; Müllinger B; Sommerer K; Scheuch G; Brand P; Beckmann H; Häussinger K; Weber N; Siekmeier R
    Exp Lung Res; 2003; 29(7):475-84. PubMed ID: 14710439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pulmonary deposition of two aerosol preparations of nedocromil sodium delivered by MDI assessed by single photon emission computed tomography.
    Summers QA; Fleming JS; Dai Y; Perring S; Honeywell R; Gough KJ; Renwick AG; Clark AR; Nassim MA; Holgate ST
    J Aerosol Med; 1996 Mar; 9 Suppl 1():S93-109. PubMed ID: 10160062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of nebulizer configuration on delivery of aerosolized tobramycin.
    O'Riordan TG; Amram JC
    J Aerosol Med; 1997; 10(1):13-23. PubMed ID: 10166359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site of deposition and absorption of an inhaled hydrophilic solute.
    Bondesson E; Bengtsson T; Nilsson LE; Wollmer P
    Br J Clin Pharmacol; 2007 Jun; 63(6):722-31. PubMed ID: 17244190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aerosol deposition in the human lung periphery is increased by reduced-density gas breathing.
    Peterson JB; Prisk GK; Darquenne C
    J Aerosol Med Pulm Drug Deliv; 2008 Jun; 21(2):159-68. PubMed ID: 18518792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose delivery characteristics of the AIR pulmonary delivery system over a range of inspiratory flow rates.
    DeLong M; Wright J; Dawson M; Meyer T; Sommerer K; Dunbar C
    J Aerosol Med; 2005; 18(4):452-9. PubMed ID: 16379620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional deposition and retention of particles in shallow, inhaled boluses: effect of lung volume.
    Bennett WD; Scheuch G; Zeman KL; Brown JS; Kim C; Heyder J; Stahlhofen W
    J Appl Physiol (1985); 1999 Jan; 86(1):168-73. PubMed ID: 9887127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging the postdeposition dispersion of an inhaled surfactant aerosol.
    Corcoran TE; Thomas KM; Garoff S; Tilton RD; Przybycien TM; Pilewski JM
    J Aerosol Med Pulm Drug Deliv; 2012 Oct; 25(5):290-6. PubMed ID: 22393908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary deposition sites of an inhaled radiolabeled submicronic aerosol.
    Kay J; Coates G; O'Brodovich H
    Pediatr Res; 1986 Dec; 20(12):1297-300. PubMed ID: 3797121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucociliary clearance mechanism in smoking and nonsmoking normal subjects.
    Isawa T; Teshima T; Hirano T; Ebina A; Konno K
    J Nucl Med; 1984 Mar; 25(3):352-9. PubMed ID: 6230423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhaled aerosol dose distribution between proximal bronchi and lung periphery.
    Verbanck S; Biddiscombe MF; Usmani OS
    Eur J Pharm Biopharm; 2020 Jul; 152():18-22. PubMed ID: 32361031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory flow phenomena and gravitational deposition in a three-dimensional space-filling model of the pulmonary acinar tree.
    Sznitman J; Heimsch T; Wildhaber JH; Tsuda A; Rösgen T
    J Biomech Eng; 2009 Mar; 131(3):031010. PubMed ID: 19154069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artificial neural network prediction of the patterns of deposition of polydisperse aerosols within human lungs.
    Nazir J; Barlow DJ; Jayne Lawrence M; Shrubb I
    J Pharm Sci; 2005 Sep; 94(9):1986-97. PubMed ID: 16052546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of energy on propylene glycol aerosols using the capillary aerosol generator.
    Shen X; Hindle M; Byron PR
    Int J Pharm; 2004 May; 275(1-2):249-58. PubMed ID: 15081155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional deposition of inhaled hygroscopic aerosols: in vivo SPECT compared with mathematical modeling.
    Finlay WH; Stapleton KW; Chan HK; Zuberbuhler P; Gonda I
    J Appl Physiol (1985); 1996 Jul; 81(1):374-83. PubMed ID: 8828688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.